{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:55:01Z","timestamp":1773291301757,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.annepidem.2005.01.012","type":"journal-article","created":{"date-parts":[[2005,10,11]],"date-time":"2005-10-11T07:23:11Z","timestamp":1129015391000},"page":"49-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Phenylpropanolamine and Hemorrhagic Stroke in the Hemorrhagic Stroke Project: A Reappraisal in the Context of Science, the Food and Drug Administration, and the Law"],"prefix":"10.1016","volume":"16","author":[{"given":"Byron G.","family":"Stier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2005.01.012_bib1","unstructured":"Horwitz RI, Brass LM, Kernan WN, Viscoli CM. Phenylpropanolamine & Risk of Hemorrhagic Stroke, Final Report of The Hemorrhagic Stroke Project. May 10, 2000."},{"key":"10.1016\/j.annepidem.2005.01.012_bib2","unstructured":"Woodcock J, FDA. Letter. Nov. 3, 2000."},{"key":"10.1016\/j.annepidem.2005.01.012_bib3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2005.01.012_bib4","series-title":"Epidemiology in Medicine","author":"Hennekens","year":"1987"},{"key":"10.1016\/j.annepidem.2005.01.012_bib5","unstructured":"Voigt LV. Expert Report. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Jan. 2, 2003."},{"key":"10.1016\/j.annepidem.2005.01.012_bib6","unstructured":"Horwitz RI, Brass LM, Kernan WN, Singer BH, Viscoli CM. Hemorrhagic Stroke Project: Case-Control Study of PPA and Hemorrhagic Stroke. April 1994."},{"key":"10.1016\/j.annepidem.2005.01.012_bib7","unstructured":"Schlesselman JJ. Expert Report. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Jan. 6, 2003."},{"key":"10.1016\/j.annepidem.2005.01.012_bib8","unstructured":"Brass LM. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Oct. 1, 4, 10, 2002."},{"key":"10.1016\/j.annepidem.2005.01.012_bib9","unstructured":"Viscoli CM. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Oct. 21\u201322, 2002."},{"key":"10.1016\/j.annepidem.2005.01.012_bib10","unstructured":"Kernan WN. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Sept. 18\u201319, 2002."},{"key":"10.1016\/j.annepidem.2005.01.012_bib11","unstructured":"Sauerbeck L. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Nov. 13, 2002."},{"key":"10.1016\/j.annepidem.2005.01.012_bib12","unstructured":"Krompf K. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Oct. 29\u201330, 2002."},{"key":"10.1016\/j.annepidem.2005.01.012_bib13","unstructured":"Horwitz RI, Memorandum to Guinn PF. Aug. 15, 2000."},{"key":"10.1016\/j.annepidem.2005.01.012_bib14","unstructured":"Littlejohn TJ. Deposition. In re Phenylpropanolamine Prod. Liab. Litig., No. MDL. 1407 (W.D. Wash.) (BJR). Dec. 19, 2002."},{"key":"10.1016\/j.annepidem.2005.01.012_bib15","unstructured":"Consumer Healthcare Products Association. Points to Consider in Review of the Hemorrhagic Stroke Project: Case-Control Study of Phenylpropanolamine (PPA) and Hemorrhagic Stroke. May 9, 2000."},{"key":"10.1016\/j.annepidem.2005.01.012_bib16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM199511233332106","article-title":"Primary prevention of stroke","volume":"333","author":"Bronner","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2005.01.012_bib17","article-title":"Dow Corning in bankruptcy over lawsuits","author":"Feder","year":"1995","journal-title":"NYT"},{"key":"10.1016\/j.annepidem.2005.01.012_bib18","series-title":"Chronology of FDA Breast Implants Activities","author":"FDA","year":"2000"},{"key":"10.1016\/j.annepidem.2005.01.012_bib19","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199406163302401","article-title":"Risk of Connective-Tissue Diseases and Other Disorders after Breast Implantation","volume":"330","author":"Gabriel","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2005.01.012_bib20","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM199506223322502","article-title":"Silicone breast implants and the risk of connective-tissue diseases and symptoms","volume":"332","author":"S\u00e1nchez-Guerrero","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2005.01.012_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.1996.03530320040032","article-title":"Self-reported breast implants and connective-tissue diseases in female health professionals","volume":"275","author":"Hennekens","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2005.01.012_bib22","unstructured":"Diamond BA, Hulka BS, Kerkvliet NI, Tugwell P. Silicone Breast Implants in Relation to Connective Tissue Diseases and Immunologic Dysfunction. Report by National Science Panel to the Honorable Sam C. Pointer, Jr., Coordinating Judge for the Federal Breast Implant Multidistrict Litigation. November 17, 1998."},{"key":"10.1016\/j.annepidem.2005.01.012_bib23","series-title":"Safety of Silicone Breast Implants","article-title":"Institute of Medicine","author":"Bondurant","year":"2000"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279705002681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279705002681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:01:37Z","timestamp":1760925697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279705002681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1047279705002681"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2005.01.012","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylpropanolamine and Hemorrhagic Stroke in the Hemorrhagic Stroke Project: A Reappraisal in the Context of Science, the Food and Drug Administration, and the Law","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2005.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}